Switzerland authorizes Moderna's COVID vaccine for 6-11 year olds

Moderna Inc said on Friday that Swiss drugs regulator Swissmedic had authorized the use of its COVID-19 vaccine for children aged 6 to 11 years.

The approval is for the vaccine's two-dose series of 50 micrograms per dose, Moderna added.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)